Alantra has been appointed Corporate Broker to Farmacosmo S.p.A
SECTORConsumer Goods & Retail
ServiceEquity Capital Markets
Milan – Alantra has been appointed corporate broker to Farmacosmo SpA, providing equity research and fostering engagement with Italian and international institutional investors.
Farmacosmo SpA is an Italian e-commerce platform specializing in health, beauty, and wellness. Its offerings include OTC pharmaceuticals, dermo-cosmetics, personal and pet care products, dietary supplements, and telepsychology services via ContactU.
Founded in 2014, the company has rapidly scaled by leveraging a “sell-and-buy” model to minimize inventory risk and achieving an average order value above industry standards. Its customer-centric approach, focus on digital health, expanded product catalogue, and M&A activity have fueled growth across multiple sectors.
With a diversified business model encompassing e-commerce, a physical pharmacy, and digital health services, Farmacosmo is positioned as a comprehensive wellness platform.
Related Transactions
-
Aug 2026
Sell-side advisory
Aug 2026SECTOR Consumer Goods & RetailSUBSECTOR Food & BeverageService M&A -
Jul 2026
Sell-side advisory / Carve-out
Jul 2026SECTOR Consumer Goods & RetailService M&A -
Jul 2026
Lead ManagerValue €100mnJul 2026SECTOR Consumer Goods & RetailService Equity Capital MarketsValue €100mn -
Jun 2026
Sell-side advisory
Jun 2026SECTOR Consumer Goods & Retail; HealthcareService M&A